FibroGen Cash from Financing (TTM) Analysis

FibroGen Inc (FGEN)

1.16 -0.11 (-8.66%) USD | NASDAQ | Apr 18, 16:00

1.165 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	122.75M
September 30, 2023	171.67M
June 30, 2023	170.60M
March 31, 2023	81.15M
December 31, 2022	46.78M
September 30, 2022	-1.929M
June 30, 2022	-1.67M
March 31, 2022	-1.376M
December 31, 2021	-0.563M
September 30, 2021	5.127M
June 30, 2021	10.18M
March 31, 2021	12.45M
December 31, 2020	13.34M
September 30, 2020	7.40M
June 30, 2020	-0.061M
March 31, 2020	-1.956M
December 31, 2019	-4.30M
September 30, 2019	-1.198M
June 30, 2019	5.958M

Date	Value
March 31, 2019	8.296M
December 31, 2018	13.88M
September 30, 2018	14.47M
June 30, 2018	380.58M
March 31, 2018	497.94M
December 31, 2017	496.47M
September 30, 2017	496.20M
June 30, 2017	127.27M
March 31, 2017	7.461M
December 31, 2016	6.738M
September 30, 2016	7.718M
June 30, 2016	9.443M
March 31, 2016	11.58M
December 31, 2015	12.35M
September 30, 2015	183.88M
June 30, 2015	180.04M
March 31, 2015	174.78M
December 31, 2014	174.09M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-4.30M

Minimum

Dec 2019

171.67M

Maximum

Sep 2023

33.39M

Average

5.958M

Median

Jun 2019

Cash from Financing (TTM) Benchmarks